{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:12:46Z","timestamp":1787933566866,"version":"build-2784847793"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12664-026-01989-3","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:12:50Z","timestamp":1777641170000},"page":"452-473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exclusive enteral nutrition for induction of remission in Crohn\u2019s disease in adults: A systematic review and meta-analysis of randomized trials and real-world studies"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8530-9493","authenticated-orcid":false,"given":"Kirandeep","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7163-0454","authenticated-orcid":false,"given":"Arshdeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5238-2255","authenticated-orcid":false,"given":"Simrat","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0524-2696","authenticated-orcid":false,"given":"Riya","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6578-7480","authenticated-orcid":false,"given":"Sanya","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5820-7758","authenticated-orcid":false,"given":"Arshia","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9074-6698","authenticated-orcid":false,"given":"Anuraag","family":"Jena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6726-6151","authenticated-orcid":false,"given":"Ramit","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0192-3969","authenticated-orcid":false,"given":"Vandana","family":"Midha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6961-6389","authenticated-orcid":false,"given":"Ajit","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"issue":"10432","key":"1989_CR1","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0140-6736(23)02586-2","volume":"403","author":"M Dolinger","year":"2024","unstructured":"Dolinger M, Torres J, Vermeire S. Crohn\u2019s disease. Lancet. 2024;403:1177\u201391. https:\/\/doi.org\/10.1016\/S0140-6736(23)02586-2.","journal-title":"Lancet"},{"issue":"1","key":"1989_CR2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s12664-023-01430-z","volume":"43","author":"K Dharni","year":"2024","unstructured":"Dharni K, Singh A, Sharma S, et al. Trends of inflammatory bowel disease from the Global Burden of Disease Study (1990-2019). Indian J Gastroenterol. 2024;43:188\u201398. https:\/\/doi.org\/10.1007\/s12664-023-01430-z.","journal-title":"Indian J Gastroenterol"},{"issue":"2","key":"1989_CR3","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.immuni.2023.01.002","volume":"56","author":"L Kong","year":"2023","unstructured":"Kong L, Pokatayev V, Lefkovith A, et al. The landscape of immune dysregulation in Crohn\u2019s disease revealed through single-cell transcriptomic profiling in the ileum and colon. Immunity. 2023;56:444\u201358.e5. https:\/\/doi.org\/10.1016\/j.immuni.2023.01.002.","journal-title":"Immunity"},{"issue":"1","key":"1989_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/gidisord1010007","volume":"1","author":"AE M\u2019Koma","year":"2019","unstructured":"M\u2019Koma AE. The multifactorial etiopathogeneses interplay of inflammatory bowel disease: An overview. Gastrointest Disord Basel Switz. 2019;1:75\u2013105. https:\/\/doi.org\/10.3390\/gidisord1010007.","journal-title":"Gastrointest Disord Basel Switz"},{"key":"1989_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1475222","volume":"15","author":"H Su","year":"2024","unstructured":"Su H, Xiao S, Liang Z, Xun T, Zhang J, Yang X. Systematic review and bayesian network meta-analysis: comparative efficacy and safety of six commonly used biologic therapies for moderate-to-severe Crohn\u2019s disease. Front Pharmacol. 2024;15:1475222. https:\/\/doi.org\/10.3389\/fphar.2024.1475222.","journal-title":"Front Pharmacol"},{"issue":"12","key":"1989_CR6","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S2468-1253(21)00312-5","volume":"6","author":"S Singh","year":"2021","unstructured":"Singh S, Murad MH, Fumery M, et al. Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn\u2019s disease: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. 2021;6:1002\u201314. https:\/\/doi.org\/10.1016\/S2468-1253(21)00312-5.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"22","key":"1989_CR7","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.3748\/wjg.v30.i22.2902","volume":"30","author":"N Vootukuru","year":"2024","unstructured":"Vootukuru N, Vasudevan A. Approach to loss of response to advanced therapies in inflammatory bowel disease. World J Gastroenterol. 2024;30:2902\u201319. https:\/\/doi.org\/10.3748\/wjg.v30.i22.2902.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"1989_CR8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/apt.17109","volume":"56","author":"MH Sohouli","year":"2022","unstructured":"Sohouli MH, Fatahi S, Farahmand F, Alimadadi H, Seraj SS, Rohani P. Meta-analysis: efficacy of exclusive enteral nutrition as induction therapy on disease activity index, inflammation and growth factors in paediatric Crohn\u2019s disease. Aliment Pharmacol Ther. 2022;56:384\u201395. https:\/\/doi.org\/10.1111\/apt.17109.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"1989_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12519-018-0204-0","volume":"15","author":"Y Yu","year":"2019","unstructured":"Yu Y, Chen KC, Chen J. Exclusive enteral nutrition versus corticosteroids for treatment of pediatric Crohn\u2019s disease: a meta-analysis. World J Pediatr. 2019;15:26\u201336. https:\/\/doi.org\/10.1007\/s12519-018-0204-0.","journal-title":"World J Pediatr"},{"issue":"3","key":"1989_CR10","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.clnu.2022.12.004","volume":"42","author":"SC Bischoff","year":"2023","unstructured":"Bischoff SC, Bager P, Escher J, et al. ESPEN guideline on clinical nutrition in inflammatory bowel disease. Clin Nutr. 2023;42:352\u201379. https:\/\/doi.org\/10.1016\/j.clnu.2022.12.004.","journal-title":"Clin Nutr"},{"key":"1989_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2147\/CEG.S267172","volume":"14","author":"R de Sire","year":"2021","unstructured":"de Sire R, Nardone OM, Testa A, Calabrese G, Caiazzo A, Castiglione F. Exclusive enteral nutrition in adult Crohn\u2019s disease: an overview of clinical practice and perceived barriers. Clin Exp Gastroenterol. 2021;14:493\u2013501. https:\/\/doi.org\/10.2147\/CEG.S267172.","journal-title":"Clin Exp Gastroenterol"},{"issue":"2","key":"1989_CR12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/jhn.12829","volume":"34","author":"RN Mutsekwa","year":"2021","unstructured":"Mutsekwa RN, Edwards JT, Angus RL. Exclusive enteral nutrition in the management of Crohn\u2019s disease: a qualitative exploration of experiences, challenges and enablers in adult patients. J Hum Nutr Diet. 2021;34:440\u20139. https:\/\/doi.org\/10.1111\/jhn.12829.","journal-title":"J Hum Nutr Diet"},{"issue":"9","key":"1989_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/nu17091481","volume":"17","author":"A Bargas","year":"2025","unstructured":"Bargas A, Palmela C, Gl\u00f3ria L. Enteral nutrition in Crohn\u2019s disease: A comprehensive review of its role in induction and maintenance of remission and perioperative management in adult patients. Nutrients. 2025;17:1481. https:\/\/doi.org\/10.3390\/nu17091481.","journal-title":"Nutrients"},{"issue":"9","key":"1989_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138237","volume":"10","author":"NR Haddaway","year":"2015","unstructured":"Haddaway NR, Collins AM, Coughlin D, Kirk S. The role of Google scholar in evidence reviews and its applicability to grey literature searching. PLoS One. 2015;10:e0138237. https:\/\/doi.org\/10.1371\/journal.pone.0138237.","journal-title":"PLoS One"},{"issue":"1","key":"1989_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10:89. https:\/\/doi.org\/10.1186\/s13643-021-01626-4.","journal-title":"Syst Rev"},{"issue":"21","key":"1989_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/nu16213581","volume":"16","author":"R Geesala","year":"2024","unstructured":"Geesala R, Gongloor P, Recharla N, Shi XZ. Mechanisms of action of exclusive enteral nutrition and other nutritional therapies in Crohn\u2019s disease. Nutrients. 2024;16:3581. https:\/\/doi.org\/10.3390\/nu16213581.","journal-title":"Nutrients"},{"issue":"3","key":"1989_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","volume":"70","author":"WR Best","year":"1976","unstructured":"Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn\u2019s disease activity index. National Cooperative Crohn\u2019s Disease Study. Gastroenterology. 1976;70:439\u201344.","journal-title":"Gastroenterology"},{"issue":"8167","key":"1989_CR18","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/s0140-6736(80)92767-1","volume":"1","author":"RF Harvey","year":"1980","unstructured":"Harvey RF, Bradshaw JM. A simple index of Crohn\u2019s-disease activity. Lancet. 1980;1:514. https:\/\/doi.org\/10.1016\/s0140-6736(80)92767-1.","journal-title":"Lancet Lond Engl"},{"key":"1989_CR19","doi-asserted-by":"publisher","unstructured":"van Hees PA, van Elteren PH, van Lier HJ, van Tongeren JH. An index of inflammatory activity in patients with Crohn\u2019s disease. Gut. 1980;21:279\u201386. https:\/\/doi.org\/10.1136\/gut.21.4.279.","DOI":"10.1136\/gut.21.4.279"},{"key":"1989_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00365521.1984.12199901","volume":"95","author":"J Myren","year":"1984","unstructured":"Myren J, Bouchier IA, Watkinson G, Softley A, Clamp SE, de Dombal FT. The O.M.G.E. multinational inflammatory bowel disease survey 1976-1982. A further report on 2,657 cases. Scand J Gastroenterol Suppl. 1984;95:1\u201327.","journal-title":"Scand J Gastroenterol Suppl"},{"key":"1989_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. https:\/\/doi.org\/10.1136\/bmj.d5928.","journal-title":"BMJ"},{"key":"1989_CR22","unstructured":"Ottawa Hospital Research Institute. https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp.\u00a0Accessed 15 September 2025."},{"issue":"4","key":"1989_CR23","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.clnu.2018.08.022","volume":"38","author":"Y Xu","year":"2019","unstructured":"Xu Y, Guo Z, Cao L, et al. Isolated colonic Crohn\u2019s disease is associated with a reduced response to exclusive enteral nutrition compared to ileal or ileocolonic disease. Clin Nutr. 2019;38:1629\u201335. https:\/\/doi.org\/10.1016\/j.clnu.2018.08.022.","journal-title":"Clin Nutr"},{"key":"1989_CR24","doi-asserted-by":"publisher","DOI":"10.1177\/1756284819881301","volume":"12","author":"Y Xu","year":"2019","unstructured":"Xu Y, Guo Z, Huang L, et al. A nomogram for predicting the response to exclusive enteral nutrition in adult patients with isolated colonic Crohn\u2019s disease. Ther Adv Gastroenterol. 2019;12:1756284819881301. https:\/\/doi.org\/10.1177\/1756284819881301.","journal-title":"Ther Adv Gastroenterol"},{"issue":"7","key":"1989_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.70207","volume":"9","author":"MKW Chu","year":"2025","unstructured":"Chu MKW, Day AS, Bogatic D, et al. Frequent dietetic involvement enhances adherence and clinical outcomes of exclusive enteral nutrition in adults with Crohn\u2019s disease. JGH Open. 2025;9:e70207. https:\/\/doi.org\/10.1002\/jgh3.70207.","journal-title":"JGH Open"},{"issue":"24","key":"1989_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/nu15245091","volume":"15","author":"N Diao","year":"2023","unstructured":"Diao N, Liu X, Lin M, et al. Exclusive enteral nutrition orchestrates immunological balances as early as week 4 in adult patients of Crohn\u2019s disease: A pilot, open-lable study. Nutrients. 2023;15:5091. https:\/\/doi.org\/10.3390\/nu15245091.","journal-title":"Nutrients"},{"issue":"4","key":"1989_CR27","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1177\/0884533613487218","volume":"28","author":"Z Guo","year":"2013","unstructured":"Guo Z, Wu R, Zhu W, et al. Effect of exclusive enteral nutrition on health-related quality of life for adults with active Crohn\u2019s disease. Nutr Clin Pract. 2013;28:499\u2013505. https:\/\/doi.org\/10.1177\/0884533613487218.","journal-title":"Nutr Clin Pract"},{"issue":"8","key":"1989_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/nu8080519","volume":"8","author":"Z Guo","year":"2016","unstructured":"Guo Z, Gong J, Li Y, et al. Mucosal microRNAs expression profiles before and after exclusive enteral nutrition therapy in adult patients with Crohn\u2019s disease. Nutrients. 2016;8:519. https:\/\/doi.org\/10.3390\/nu8080519.","journal-title":"Nutrients"},{"issue":"9","key":"1989_CR29","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1097\/MCG.0000000000000041","volume":"48","author":"D Hu","year":"2014","unstructured":"Hu D, Ren J, Wang G, et al. Exclusive enteral nutritional therapy can relieve inflammatory bowel stricture in Crohn\u2019s disease. J Clin Gastroenterol. 2014;48:790\u20135. https:\/\/doi.org\/10.1097\/MCG.0000000000000041.","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"1989_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-022-02293-y","volume":"22","author":"J Jiang","year":"2022","unstructured":"Jiang J, Chen L, Chen Y, Chen H. Exclusive enteral nutrition remodels the intestinal flora in patients with active Crohn\u2019s disease. BMC Gastroenterol. 2022;22:212. https:\/\/doi.org\/10.1186\/s12876-022-02293-y.","journal-title":"BMC Gastroenterol"},{"issue":"9","key":"1989_CR31","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1097\/MIB.0000000000000114","volume":"20","author":"Y Li","year":"2014","unstructured":"Li Y, Zhu W, Gong J, et al. Influence of exclusive enteral nutrition therapy on visceral fat in patients with Crohn\u2019s disease. Inflamm Bowel Dis. 2014;20:1568\u201374. https:\/\/doi.org\/10.1097\/MIB.0000000000000114.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"1989_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/flgastro-2022-102173","volume":"14","author":"SL Melton","year":"2023","unstructured":"Melton SL, Fitzpatrick JA, Taylor KM, Halmos EP, Gibson PR. Lessons from an audit of exclusive enteral nutrition in adult inpatients and outpatients with active Crohn\u2019s disease: a single-centre experience. Frontline Gastroenterol. 2023;14:6\u201312. https:\/\/doi.org\/10.1136\/flgastro-2022-102173.","journal-title":"Frontline Gastroenterol"},{"issue":"1","key":"1989_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4103\/1319-3767.199110","volume":"23","author":"M Nakano","year":"2017","unstructured":"Nakano M, Tominaga K, Hoshino A, Sugaya T, Kanke K, Hiraishi H. Therapeutic efficacy of an elemental diet for patients with Crohn\u2019s disease and its association with amino acid metabolism. Saudi J Gastroenterol. 2017;23:20\u20137. https:\/\/doi.org\/10.4103\/1319-3767.199110.","journal-title":"Saudi J Gastroenterol Off J Saudi Gastroenterol Assoc"},{"issue":"3","key":"1989_CR34","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/jhn.12979","volume":"35","author":"L Purcell","year":"2022","unstructured":"Purcell L, Mutsekwa R, Angus R, Shukla D, Palmer M. Is the frequency of dietitian support associated with greater clinical improvements in adults with Crohn\u2019s disease undertaking exclusive enteral nutrition? J Hum Nutr Diet. 2022;35:435\u201343. https:\/\/doi.org\/10.1111\/jhn.12979.","journal-title":"J Hum Nutr Diet"},{"issue":"2","key":"1989_CR35","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/jpen.2273","volume":"46","author":"P Kakkadasam Ramaswamy","year":"2022","unstructured":"Kakkadasam Ramaswamy\u00a0P; Gold\u00a0Coast Inflammatory Bowel Diseases Research Group. Exclusive enteral nutrition with oral polymeric diet helps in inducing clinical and biochemical remission in adults with active Crohn\u2019s disease. JPEN J Parenter Enteral Nutr. 2022;46:423\u201332. https:\/\/doi.org\/10.1002\/jpen.2273.","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"3","key":"1989_CR36","doi-asserted-by":"publisher","first-page":"291","DOI":"10.5217\/ir.2019.09172","volume":"19","author":"S Sharma","year":"2021","unstructured":"Sharma S, Gupta A, Kedia S, et al. Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn\u2019s disease. Intest Res. 2021;19:291\u2013300. https:\/\/doi.org\/10.5217\/ir.2019.09172.","journal-title":"Intest Res"},{"issue":"2","key":"1989_CR37","doi-asserted-by":"publisher","first-page":"184","DOI":"10.5217\/ir.2019.00094","volume":"18","author":"A Sood","year":"2020","unstructured":"Sood A, Singh A, Sudhakar R, et al. Exclusive enteral nutrition for induction of remission in anti-tumor necrosis factor refractory adult Crohn\u2019s disease: the Indian experience. Intest Res. 2020;18:184\u201391. https:\/\/doi.org\/10.5217\/ir.2019.00094.","journal-title":"Intest Res"},{"issue":"1","key":"1989_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/0016-5085(91)90463-u","volume":"101","author":"K Teahon","year":"1991","unstructured":"Teahon K, Smethurst P, Pearson M, Levi AJ, Bjarnason I. The effect of elemental diet on intestinal permeability and inflammation in Crohn\u2019s disease. Gastroenterology. 1991;101:84\u20139. https:\/\/doi.org\/10.1016\/0016-5085(91)90463-u.","journal-title":"Gastroenterology"},{"issue":"1","key":"1989_CR39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3109\/00365529509093236","volume":"30","author":"K Teahon","year":"1995","unstructured":"Teahon K, Pearson M, Smith T, Bjarnason I. Alterations in nutritional status and disease activity during treatment of Crohn\u2019s disease with elemental diet. Scand J Gastroenterol. 1995;30:54\u201360. https:\/\/doi.org\/10.3109\/00365529509093236.","journal-title":"Scand J Gastroenterol"},{"key":"1989_CR40","unstructured":"Triantafillidis J, Stamataki A, Gikas A, et al. Beneficial effect of a polymeric feed, rich in TGF-\u03b2, on adult patients with active Crohn\u2019s disease: a pilot study. Ann Gastroenterol. 2006;19:66\u201371."},{"issue":"8","key":"1989_CR41","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41430-018-0198-7","volume":"72","author":"M Xue","year":"2018","unstructured":"Xue M, Zhang H, Wang X, et al. Efficacy predictors of a 2-month exclusive enteral nutrition for inducing remission of active Crohn\u2019s disease. Eur J Clin Nutr. 2018;72:1183\u20136. https:\/\/doi.org\/10.1038\/s41430-018-0198-7.","journal-title":"Eur J Clin Nutr"},{"issue":"6","key":"1989_CR42","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/01.mib.0000161307.58327.96","volume":"11","author":"T Yamamoto","year":"2005","unstructured":"Yamamoto T, Nakahigashi M, Umegae S, Kitagawa T, Matsumoto K. Impact of elemental diet on mucosal inflammation in patients with active Crohn\u2019s disease: cytokine production and endoscopic and histological findings. Inflamm Bowel Dis. 2005;11:580\u20138. https:\/\/doi.org\/10.1097\/01.mib.0000161307.58327.96.","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"1989_CR43","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1080\/00365521.2017.1335770","volume":"52","author":"Q Yang","year":"2017","unstructured":"Yang Q, Gao X, Chen H, et al. Efficacy of exclusive enteral nutrition in complicated Crohn\u2019s disease. Scand J Gastroenterol. 2017;52:995\u20131001. https:\/\/doi.org\/10.1080\/00365521.2017.1335770.","journal-title":"Scand J Gastroenterol"},{"issue":"19","key":"1989_CR44","doi-asserted-by":"publisher","DOI":"10.21037\/atm-22-4225","volume":"10","author":"Q Yang","year":"2022","unstructured":"Yang Q, Huang Z, Diao N, et al. Lipidomics reveals significant alterations associated with exclusive enteral nutrition treatment in adult patients with active Crohn\u2019s disease. Ann Transl Med. 2022;10:1062. https:\/\/doi.org\/10.21037\/atm-22-4225.","journal-title":"Ann Transl Med"},{"key":"1989_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2025.113007","volume":"143","author":"Y Yang","year":"2025","unstructured":"Yang Y, Zhu F, Wu Q, et al. Efficacy of exclusive enteral nutrition as a salvage therapy in adults with Crohn\u2019s disease refractory to biologic treatment.\u00a0Nutrition. 2026;143:113007. https:\/\/doi.org\/10.1016\/j.nut.2025.113007.","journal-title":"Nutr Burbank Los Angel Cty Calif"},{"issue":"4","key":"1989_CR46","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3748\/wjg.v21.i4.1299","volume":"21","author":"J Zhao","year":"2015","unstructured":"Zhao J, Dong JN, Gong JF, et al. Impact of enteral nutrition on energy metabolism in patients with Crohn\u2019s disease. World J Gastroenterol. 2015;21:1299\u2013304. https:\/\/doi.org\/10.3748\/wjg.v21.i4.1299.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1989_CR47","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/gut.51.2.164","volume":"51","author":"MA Gassull","year":"2002","unstructured":"Gassull MA, Fern\u00e1ndez-Ba\u00f1ares F, Cabr\u00e9 E, et al. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn\u2019s disease: results of a double blind randomised multicentre European trial. Gut. 2002;51:164\u20138. https:\/\/doi.org\/10.1136\/gut.51.2.164.","journal-title":"Gut"},{"issue":"6","key":"1989_CR48","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1136\/gut.34.6.778","volume":"34","author":"F Gonz\u00e1lez-Huix","year":"1993","unstructured":"Gonz\u00e1lez-Huix F, de Le\u00f3n R, Fern\u00e1ndez-Ba\u00f1ares F, et al. Polymeric enteral diets as primary treatment of active Crohn\u2019s disease: a prospective steroid controlled trial. Gut. 1993;34:778\u201382. https:\/\/doi.org\/10.1136\/gut.34.6.778.","journal-title":"Gut"},{"issue":"4","key":"1989_CR49","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/s0025-6196(12)61547-x","volume":"67","author":"KD Lindor","year":"1992","unstructured":"Lindor KD, Fleming CR, Burnes JU, Nelson JK, Ilstrup DM. A randomized prospective trial comparing a defined formula diet, corticosteroids, and a defined formula diet plus corticosteroids in active Crohn\u2019s disease. Mayo Clin Proc. 1992;67:328\u201333. https:\/\/doi.org\/10.1016\/s0025-6196(12)61547-x.","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"1989_CR50","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/0016-5085(91)90711-s","volume":"101","author":"H Lochs","year":"1991","unstructured":"Lochs H, Steinhardt HJ, Klaus-Wentz B, et al. Comparison of enteral nutrition and drug treatment in active Crohn\u2019s disease. Gastroenterology. 1991;101:881\u20138. https:\/\/doi.org\/10.1016\/0016-5085(91)90711-s.","journal-title":"Gastroenterology"},{"key":"1989_CR51","doi-asserted-by":"crossref","unstructured":"Malchow H, Steinhardt HJ, Lorenz-Meyer H, et al. Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn\u2019s disease. European Cooperative Crohn\u2019s Disease Study III. Scand J Gastroenterol. 1990;25:235\u201344.","DOI":"10.1080\/00365521.1990.12067097"},{"issue":"2","key":"1989_CR52","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/00042737-200302000-00008","volume":"15","author":"T Bamba","year":"2003","unstructured":"Bamba T, Shimoyama T, Sasaki M, et al. Dietary fat attenuates the benefits of an elemental diet in active Crohn\u2019s disease: a randomized, controlled trial. Eur J Gastroenterol Hepatol. 2003;15:151\u20137. https:\/\/doi.org\/10.1097\/00042737-200302000-00008.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8693","key":"1989_CR53","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/0140-6736(90)90936-y","volume":"335","author":"MH Giaffer","year":"1990","unstructured":"Giaffer MH, North G, Holdsworth CD. Controlled trial of polymeric versus elemental diet in treatment of active Crohn\u2019s disease. Lancet. 1990;335:816\u20139. https:\/\/doi.org\/10.1016\/0140-6736(90)90936-y.","journal-title":"Lancet"},{"issue":"6","key":"1989_CR54","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1136\/gut.49.6.790","volume":"49","author":"K Leiper","year":"2001","unstructured":"Leiper K, Woolner J, Mullan MM, et al. A randomised controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn\u2019s disease. Gut. 2001;49:790\u20134. https:\/\/doi.org\/10.1136\/gut.49.6.790.","journal-title":"Gut"},{"issue":"1","key":"1989_CR55","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/gut.36.1.60","volume":"36","author":"JC Mansfield","year":"1995","unstructured":"Mansfield JC, Giaffer MH, Holdsworth CD. Controlled trial of oligopeptide versus amino acid diet in treatment of active Crohn\u2019s disease. Gut. 1995;36:60\u20136. https:\/\/doi.org\/10.1136\/gut.36.1.60.","journal-title":"Gut"},{"issue":"4","key":"1989_CR56","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/s0261-5614(95)80004-2","volume":"14","author":"SJ Middleton","year":"1995","unstructured":"Middleton SJ, Rucker JT, Kirby GA, Riordan AM, Hunter JO. Long-chain triglycerides reduce the efficacy of enteral feeds in patients with active Crohn\u2019s disease. Clin Nutr. 1995;14:229\u201336. https:\/\/doi.org\/10.1016\/s0261-5614(95)80004-2.","journal-title":"Clin Nutr"},{"issue":"6","key":"1989_CR57","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1136\/gut.32.6.702","volume":"32","author":"AH Raouf","year":"1991","unstructured":"Raouf AH, Hildrey V, Daniel J, et al. Enteral feeding as sole treatment for Crohn\u2019s disease: controlled trial of whole protein v amino acid based feed and a case study of dietary challenge. Gut. 1991;32:702\u20137. https:\/\/doi.org\/10.1136\/gut.32.6.702.","journal-title":"Gut"},{"issue":"12","key":"1989_CR58","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1136\/gut.32.12.1492","volume":"32","author":"D Rigaud","year":"1991","unstructured":"Rigaud D, Cosnes J, Le Quintrec Y, Ren\u00e9 E, Gendre JP, Mignon M. Controlled trial comparing two types of enteral nutrition in treatment of active Crohn\u2019s disease: elemental versus polymeric diet. Gut. 1991;32:1492\u20137. https:\/\/doi.org\/10.1136\/gut.32.12.1492.","journal-title":"Gut"},{"issue":"6","key":"1989_CR59","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1136\/gut.35.6.783","volume":"35","author":"D Royall","year":"1994","unstructured":"Royall D, Jeejeebhoy KN, Baker JP, et al. Comparison of amino acid v peptide based enteral diets in active Crohn\u2019s disease: clinical and nutritional outcome. Gut. 1994;35:783\u20137. https:\/\/doi.org\/10.1136\/gut.35.6.783.","journal-title":"Gut"},{"issue":"2","key":"1989_CR60","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1177\/014860710202600298","volume":"26","author":"T Sakurai","year":"2002","unstructured":"Sakurai T, Matsui T, Yao T, et al. Short\u2010term efficacy of enteral nutrition in the treatment of active Crohn\u2019s disease: a randomized, controlled trial comparing nutrient formulas.\u00a0JPEN J Parenter Enteral Nutr.\u00a02002;26:98\u2013103. https:\/\/doi.org\/10.1177\/014860710202600298.","journal-title":"J Parenter Enteral Nutr"},{"issue":"3","key":"1989_CR61","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1572-0241.2000.01527.x","volume":"95","author":"S Verma","year":"2000","unstructured":"Verma S, Brown S, Kirkwood B, Giaffer MH. Polymeric versus elemental diet as primary treatment in active Crohn\u2019s disease: a randomized, double-blind trial. Am J Gastroenterol. 2000;95:735\u20139. https:\/\/doi.org\/10.1111\/j.1572-0241.2000.01527.x.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"1989_CR62","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1002\/cpt.70034","volume":"118","author":"H Ren","year":"2025","unstructured":"Ren H, An J, Chen W, et al. Combined biologics and exclusive enteral nutrition promote early transmural healing and improve long-term outcomes in Crohn\u2019s disease: A multicenter retrospective study. Clin Pharmacol Ther. 2025;118:1180\u201391. https:\/\/doi.org\/10.1002\/cpt.70034.","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"1989_CR63","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/j.dld.2025.06.014","volume":"57","author":"Y Song","year":"2025","unstructured":"Song Y, Peng Y, Fan X, et al. Synergistic effects of oral exclusive enteral nutrition and biologics in induction therapy for adult Crohn\u2019s disease: A real-world observational study. Dig Liver Dis. 2025;57:1778\u201386. https:\/\/doi.org\/10.1016\/j.dld.2025.06.014.","journal-title":"Dig Liver Dis"},{"issue":"7","key":"1989_CR64","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/apt.14253","volume":"46","author":"A Swaminath","year":"2017","unstructured":"Swaminath A, Feathers A, Ananthakrishnan AN, Falzon L, Li Ferry S. Systematic review with meta-analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn\u2019s disease. Aliment Pharmacol Ther. 2017;46:645\u201356. https:\/\/doi.org\/10.1111\/apt.14253.","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"1989_CR65","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1017\/S0007114523000405","volume":"130","author":"Z Ding","year":"2023","unstructured":"Ding Z, Ninan K, Johnston BC, Moayyedi P, Sherlock M, Zachos M. Microbiota signatures and mucosal healing in the use of enteral nutrition therapy v. corticosteroids for the treatment of children with Crohn\u2019s disease: a systematic review and meta-analysis. Br J Nutr. 2023;130:1385\u20131402. https:\/\/doi.org\/10.1017\/S0007114523000405.","journal-title":"Br J Nutr"},{"key":"1989_CR66","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.18692","volume":"12","author":"J Ma","year":"2024","unstructured":"Ma J, Chong J, Qiu Z, Wang Y, Chen T, Chen Y. Efficacy of different dietary therapy strategies in active pediatric Crohn\u2019s disease: a systematic review and network meta-analysis. PeerJ. 2024;12:e18692. https:\/\/doi.org\/10.7717\/peerj.18692.","journal-title":"PeerJ"},{"key":"1989_CR67","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/482108","volume":"2013","author":"S Kansal","year":"2013","unstructured":"Kansal S, Wagner J, Kirkwood CD, Catto-Smith AG. Enteral nutrition in Crohn\u2019s disease: an underused therapy. Gastroenterol Res Pract. 2013;2013:482108. https:\/\/doi.org\/10.1155\/2013\/482108.","journal-title":"Gastroenterol Res Pract"},{"issue":"4","key":"1989_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000542.pub3","volume":"4","author":"N Narula","year":"2018","unstructured":"Narula N, Dhillon A, Zhang D, Sherlock ME, Tondeur M, Zachos M. Enteral nutritional therapy for induction of remission in Crohn\u2019s disease. Cochrane Database Syst Rev. 2018;4:CD000542. https:\/\/doi.org\/10.1002\/14651858.CD000542.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"1989_CR69","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1177\/0148607195019005356","volume":"19","author":"F Fern\u00e1ndez-Banares","year":"1995","unstructured":"Fern\u00e1ndez-Banares F, Cabr\u00e9 E, Esteve-Comas M, Gassull MA. How effective is enteral nutrition in inducing clinical remission in active Crohn\u2019s disease? A meta-analysis of the randomized clinical trials. JPEN J Parenter Enteral Nutr. 1995;19:356\u201364. https:\/\/doi.org\/10.1177\/0148607195019005356.","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"3","key":"1989_CR70","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3109\/00365529609004877","volume":"31","author":"A Messori","year":"1996","unstructured":"Messori A, Trallori G, D\u2019Albasio G, Milla M, Vannozzi G, Pacini F. Defined-formula diets versus steroids in the treatment of active Crohn\u2019s disease: a meta-analysis. Scand J Gastroenterol. 1996;31:267\u201372. https:\/\/doi.org\/10.3109\/00365529609004877.","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"1989_CR71","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/0016-5085(95)90203-1","volume":"108","author":"AM Griffiths","year":"1995","unstructured":"Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Meta-analysis of enteral nutrition as a primary treatment of active Crohn\u2019s disease. Gastroenterology. 1995;108:1056\u201367. https:\/\/doi.org\/10.1016\/0016-5085(95)90203-1.","journal-title":"Gastroenterology"},{"key":"1989_CR72","unstructured":"Lee D. Reverse-engineering of exclusive enteral nutrition (RE-EEN) in Crohn's disease: a multi-center trial. clinicaltrials.gov; 2025. https:\/\/clinicaltrials.gov\/study\/NCT06216899. Accessed 16 January 2026."},{"key":"1989_CR73","unstructured":"Tokmak S. Exclusive enteral nutrition in patients with ileocaecal Crohn's disease (XENIC): an open-label, multicenter, prospective, randomized clinical trial. clinicaltrials.gov; 2022. https:\/\/clinicaltrials.gov\/study\/NCT04921033. Accessed 16 January 2026."},{"key":"1989_CR74","unstructured":"Zhou W. Semi-elemental versus polymeric exclusive enteral nutrition in the preoperative optimization for patients with Crohn's disease: a randomized controlled trial. clinicaltrials.gov; 2024. https:\/\/clinicaltrials.gov\/study\/NCT06587178. Accessed 16 Jan 2026."},{"key":"1989_CR75","unstructured":"Assistance Publique - H\u00f4pitaux de Paris. Randomised trial comparing 12 months of cyclic enteral nutrition to supplementary enteral nutrition as maintenance therapy for pediatric Crohn's disease. clinicaltrials.gov; 2021. https:\/\/clinicaltrials.gov\/study\/NCT02201693. Accessed 16 January 2026."},{"key":"1989_CR76","unstructured":"Weiming Z. The effect of the exclusive enteral nutrition combined with azathioprine in maintaining remission of patients with Crohn's diseases after surgery. clinicaltrials.gov; 2023. https:\/\/clinicaltrials.gov\/study\/NCT04160325. Accessed 16 January 2026."}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-026-01989-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12664-026-01989-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-026-01989-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T07:33:30Z","timestamp":1778484810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12664-026-01989-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1989"],"URL":"https:\/\/doi.org\/10.1007\/s12664-026-01989-3","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ajit Sood received honorarium for speaker events from Pfizer India and Takeda India. The remaining authors disclose no conflicts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permission to reproduce material from other sources"}},{"value":"The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology\u00a0or the printer\/publishers are responsible for the results\/findings and contents of this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}